A comparative study of midazolam and target-controlled propofol infusion in the treatment of refractory status epilepticus

Conclusions: The choice of anesthetic agent does not seem to affect the overall outcome in RSE and SRSE. Target-controlled propofol infusion was found to be equal in its efficacy to midazolam for the treatment of RSE. High mortality might be due to SRSE secondary to the underlying brain pathology.

Source: Indian Journal of Critical Care Medicine - June 18, 2018 Category: Intensive Care Authors: Dheeraj Masapu KN Gopala Krishna Sinha Sanjib Dhrithiman Chakrabarti RC Mundlamuri Nitin Manohar P Mariamma P Satishchandra GS Umamaheswara Rao Source Type: research